Brief: HBM Considers $1.7 Billion Sale Of Swixx Biopharma- Bloomberg News
Feb 20 (Reuters) -
* HBM CONSIDERS $1.7 BILLION SALE OF SWIXX BIOPHARMA-
BLOOMBERG
NEWS
Source text: https://tinyurl.com/4tz97pf7
Further company coverage: HBMN.S
((Reuters.Briefs@thomsonreuters.com;))
Recent news on HBM Healthcare Investments AG
See all newsSwiss stocks - Factors to watch on October 23
Brief: HBM Healthcare Investments Reports Q1 Profit CHF 238 Million
Brief: HBM Healthcare Investments Posts Profit Of CHF 272 Million
Brief: SK Capital Is Said To Near Deal For Swiss Drug Distributor Swixx That Could Value Co At About 1.5 Billion Euros- Bloomberg News
Brief: Mirum Pharmaceuticals To Acquire HBM Portfolio Company Bluejay Therapeutics